Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population

The F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of th...

Full description

Bibliographic Details
Main Authors: Dian Ningtyas, Russell J. Thomson, Volga Tarlac, Shivashankar H. Nagaraj, Wendy Hoy, John D. Mathews, Simon J. Foote, Elizabeth E. Gardiner, Justin R. Hamilton, Brendan J. McMorran
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00432/full
id doaj-7750e3e3a71b4504a0c4bf25224be957
record_format Article
spelling doaj-7750e3e3a71b4504a0c4bf25224be9572020-11-25T02:15:57ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-04-011110.3389/fgene.2020.00432495300Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian PopulationDian Ningtyas0Russell J. Thomson1Volga Tarlac2Shivashankar H. Nagaraj3Shivashankar H. Nagaraj4Wendy Hoy5John D. Mathews6John D. Mathews7Simon J. Foote8Elizabeth E. Gardiner9Justin R. Hamilton10Brendan J. McMorran11Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaCentre for Research in Mathematics and Data Science, School of Computer, Data and Mathematical Sciences, Western Sydney University, Parramatta, NSW, AustraliaAustralian Center for Blood Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, AustraliaInstitute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, AustraliaTranslational Research Institute, Brisbane, QLD, AustraliaCentre for Chronic Disease, Faculty of Health, The University of Queensland, Brisbane, QLD, AustraliaCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, AustraliaMenzies School of Health Research, Darwin, NT, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaAustralian Center for Blood Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaThe F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of the allele indicate it may be an important determinant in the ethnic differences that exist in thrombosis and hemostasis, and for patient outcomes to PAR antagonist anti-platelet therapies. Here we determined the frequency of rs773902 in an Indigenous Australian group comprising 467 individuals from the Tiwi Islands. These people experience high rates of renal disease that may be related to platelet and PAR4 function and are potential recipients of PAR-antagonist treatments. The rs773902 minor allele frequency (Thr120) in the Tiwi Islanders was 0.32, which is similar to European and Asian groups and substantially lower than Melanesians and some African groups. Logistic regression and allele distortion testing revealed no significant associations between the variant and several markers of renal function, as well as blood glucose and blood pressure. These findings suggest that rs773902 is not an important determinant for renal disease in this Indigenous Australian group. However, the relationships between rs773902 genotype and platelet and drug responsiveness in the Tiwi, and the allele frequency in other Indigenous Australian groups should be evaluated.https://www.frontiersin.org/article/10.3389/fgene.2020.00432/fullprotease activated receptor 4rs773902renal diseaseAustralian Aboriginal and Torres Strait Islandersindigenous genetics
collection DOAJ
language English
format Article
sources DOAJ
author Dian Ningtyas
Russell J. Thomson
Volga Tarlac
Shivashankar H. Nagaraj
Shivashankar H. Nagaraj
Wendy Hoy
John D. Mathews
John D. Mathews
Simon J. Foote
Elizabeth E. Gardiner
Justin R. Hamilton
Brendan J. McMorran
spellingShingle Dian Ningtyas
Russell J. Thomson
Volga Tarlac
Shivashankar H. Nagaraj
Shivashankar H. Nagaraj
Wendy Hoy
John D. Mathews
John D. Mathews
Simon J. Foote
Elizabeth E. Gardiner
Justin R. Hamilton
Brendan J. McMorran
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
Frontiers in Genetics
protease activated receptor 4
rs773902
renal disease
Australian Aboriginal and Torres Strait Islanders
indigenous genetics
author_facet Dian Ningtyas
Russell J. Thomson
Volga Tarlac
Shivashankar H. Nagaraj
Shivashankar H. Nagaraj
Wendy Hoy
John D. Mathews
John D. Mathews
Simon J. Foote
Elizabeth E. Gardiner
Justin R. Hamilton
Brendan J. McMorran
author_sort Dian Ningtyas
title Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
title_short Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
title_full Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
title_fullStr Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
title_full_unstemmed Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
title_sort analysis of the f2lr3 (par4) single nucleotide polymorphism (rs773902) in an indigenous australian population
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2020-04-01
description The F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of the allele indicate it may be an important determinant in the ethnic differences that exist in thrombosis and hemostasis, and for patient outcomes to PAR antagonist anti-platelet therapies. Here we determined the frequency of rs773902 in an Indigenous Australian group comprising 467 individuals from the Tiwi Islands. These people experience high rates of renal disease that may be related to platelet and PAR4 function and are potential recipients of PAR-antagonist treatments. The rs773902 minor allele frequency (Thr120) in the Tiwi Islanders was 0.32, which is similar to European and Asian groups and substantially lower than Melanesians and some African groups. Logistic regression and allele distortion testing revealed no significant associations between the variant and several markers of renal function, as well as blood glucose and blood pressure. These findings suggest that rs773902 is not an important determinant for renal disease in this Indigenous Australian group. However, the relationships between rs773902 genotype and platelet and drug responsiveness in the Tiwi, and the allele frequency in other Indigenous Australian groups should be evaluated.
topic protease activated receptor 4
rs773902
renal disease
Australian Aboriginal and Torres Strait Islanders
indigenous genetics
url https://www.frontiersin.org/article/10.3389/fgene.2020.00432/full
work_keys_str_mv AT dianningtyas analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT russelljthomson analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT volgatarlac analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT shivashankarhnagaraj analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT shivashankarhnagaraj analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT wendyhoy analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT johndmathews analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT johndmathews analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT simonjfoote analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT elizabethegardiner analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT justinrhamilton analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
AT brendanjmcmorran analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation
_version_ 1724893735337066496